Suppr超能文献

先天性 V(D)J 重组缺陷。

Congenital defects in V(D)J recombination.

机构信息

Laboratory of Genome Dynamics in the Immune System, INSERM UMR1163, Université Paris Descartes Sorbonne Paris Cité, Institut Imagine, Paris, France

出版信息

Br Med Bull. 2015 Jun;114(1):157-67. doi: 10.1093/bmb/ldv020. Epub 2015 May 17.

Abstract

INTRODUCTION OR BACKGROUND

The V(D)J recombination is a DNA rearrangement process that generates the diversity of T and B lymphocyte immune repertoire. It proceeds through the generation of a DNA double-strand break (DNA-DSB) by the Rag1/2 lymphoid-specific factors, which is repaired by the non-homologous end joining (NHEJ) DNA repair pathway. V(D)J recombination also constitutes a checkpoint in the lymphoid development.

SOURCES OF DATA

V(D)J recombination defect results in severe combined immune deficiency (SCID) with a lack of T and B lymphocytes.

AREAS OF AGREEMENT

The V(D)J recombination represents one of the few programmed molecular events leading to DNA-DSBs that strictly relies on NHEJ. Two NHEJ factors, Artemis and XLF/Cernunnos, were identified through the molecular studies of SCID patients. Mutations in PRKDC and DNA Ligase IV genes also result in SCID.

GROWING POINTS

Studies in mice have demonstrated that XLF/Cernunnos is dispensable for V(D)J recombination in lymphoid cells but not for the repair of genotoxic-induced DNA-DSBs, which raises the question of the implication of Rag1/2 factors in the DNA repair phase of V(D)J recombination.

AREAS TIMELY FOR DEVELOPING RESEARCH

New factors of NHEJ, such as PAXX, are being identified. Patients with NHEJ deficiency (XRCC4) without immune deficiency were recently reported. We, therefore, may not have yet the complete picture of DNA-DSB repair in the context of V(D)J recombination.

摘要

简介或背景

V(D)J 重组是一种 DNA 重排过程,可产生 T 和 B 淋巴细胞免疫受体的多样性。它通过 Rag1/2 淋巴细胞特异性因子产生 DNA 双链断裂(DNA-DSB),然后通过非同源末端连接(NHEJ)DNA 修复途径进行修复。V(D)J 重组也是淋巴细胞发育中的一个检查点。

资料来源

V(D)J 重组缺陷导致严重联合免疫缺陷(SCID),缺乏 T 和 B 淋巴细胞。

共识领域

V(D)J 重组代表了少数几个导致 DNA-DSB 的程序化分子事件之一,严格依赖于 NHEJ。通过对 SCID 患者的分子研究,鉴定出两种 NHEJ 因子,Artemis 和 XLF/Cernunnos。PRKDC 和 DNA 连接酶 IV 基因的突变也导致 SCID。

新的研究领域

正在鉴定新的 NHEJ 因子,如 PAXX。最近报道了没有免疫缺陷的 NHEJ 缺陷(XRCC4)患者。因此,我们可能还没有完全了解 V(D)J 重组中 DNA-DSB 修复的情况。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验